We then examined the frequency of peripheral CD8+ T-lymphocytes that recognized the PBF A2.2 peptide in five HLA-A*0201+ patients with PBF-positive osteosarcoma by LD/MLPC/tetramer analysis. The gene discussed is HLA-A; the disease is osteosarcoma.